{
    "nctId": "NCT03817814",
    "briefTitle": "Decisions of Young Women With Breast Cancer Regarding Fertility Preservation Before Cancer Treatment and Family Building After Treatment",
    "officialTitle": "Decisions of Young Women With Breast Cancer Regarding Fertility Preservation Before Cancer Treatment and Family Building After Treatment",
    "overallStatus": "ACTIVE_NOT_RECRUITING",
    "conditions": "Fertility Preservation, Breast Cancer",
    "studyType": "OBSERVATIONAL",
    "phase": "N/A",
    "allocation": "N/A",
    "primaryPurpose": "N/A",
    "enrollmentCount": 209,
    "primaryOutcomeMeasure": "Patient-reported outcome questionnaire - Fertility Preservation Questionnaire",
    "eligibilityCriteria": "Inclusion Criteria:\n\n* Breast cancer, Stage 0-III\n* Female\n* 18-45 years of age at time of diagnosis\n* Patients that completed their primary breast cancer treatment (surgery, chemotherapy, radiation therapy). Patients can still be on endocrine therapy, trastuzumab and/or pertuzumab therapy.\n* Received education and counseling by MSK Fertility Nurse Specialist before beginning cancer treatment from 2009 through 2018\n\nExclusion Criteria:\n\n* Unable to read English",
    "sex": "FEMALE",
    "minimumAge": "18 Years",
    "stdAges": "ADULT"
}